pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 57 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
BW-20805
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Shanghai Argo Pharmaceutical Co Ltd
1 catalysts
Phase 2
siplizumab
Vicalex (siplizumab)
Transplant Rejection
T-cell surface antigen CD2
ITB-Med AB
1 catalysts
Phase 2
tulisokibart
Systemic Sclerosis (Scleroderma)
$MRKMerck & Co., Inc.
1 catalysts
← prev
page 1 of 2
next →
131
Pain89
Neurology1
Phase 2
(cilnidipine + tadalafil)
(cilnidipine [INN] + tadalafil)
Systemic Sclerosis (Scleroderma)
AISA Pharma Inc
0 catalysts
Phase 2
ACE-1831
Immunoglobulin G4-Related Disease (IgG4-RD)
Acepodia Inc
0 catalysts
Phase 2
AZD-0120
Refractory Multiple Myeloma
Gracell Biotechnologies Inc
0 catalysts
Phase 2
Autologous Adipose-derived Stem Cells
Osteoarthritis
CellTex Therapeutics Corp
0 catalysts
Phase 2
CA-002
Peanut Allergy
Cambridge Allergy Ltd
0 catalysts
Phase 2
CNP-106
Myasthenia Gravis
Cour Pharmaceuticals Development Co Inc
0 catalysts
Phase 2
CTO-1681
Cytokine Release Syndrome (Cytokine Storm)
CytoAgents Inc
0 catalysts
Phase 2
CYP-001
Graft Versus Host Disease (GVHD)
Cynata Therapeutics Ltd
0 catalysts
Phase 2
DBV-135
Milk Allergy
DBV Technologies SA
0 catalysts
Phase 2
DS-7011
Cutaneous Lupus Erythematosus
Daiichi Sankyo Co Ltd
0 catalysts
Phase 2
DSG3-CAART
Pemphigus Vulgaris
$CABACabaletta Bio, Inc.
0 catalysts
Phase 2
EG-501
Cognitive Impairment
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Phase 2
F-652
Alcoholic Hepatitis
IL22 Receptor
Evive Biotech
0 catalysts
Phase 2
GCC-4001
Idiopathic Inflammatory Myopathy (IIM)
$ARTVArtiva Biotherapeutics, Inc.
0 catalysts
Phase 2
Gene Therapy to Activate Artemis for Severe Combined Immune Deficiency
Severe Combined Immune Deficiency (SCID)
University of California San Francisco
0 catalysts
Phase 2
Gene Therapy to Activate IL-2 Gamma Receptor for SCID-X1
X-Linked SCID
Boston Children's Hospital
0 catalysts
Phase 2
IM-101
Myasthenia Gravis
ImmunAbs Inc
0 catalysts
Phase 2
KBLP-001
Plaque Psoriasis (Psoriasis Vulgaris)
KoBioLabs Inc
0 catalysts
Phase 2
LIS-1
Kidney Transplant Rejection
Xenothera SAS
0 catalysts
Phase 2
MaaT-013
Graft Versus Host Disease (GVHD)
MaaT Pharma SA
0 catalysts
Phase 2
NS-229
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
Nippon Shinyaku Co Ltd
0 catalysts
Phase 2
OATD-01
Pulmonary Sarcoidosis
Molecure SA
0 catalysts
Phase 2
ORKA-001
Plaque Psoriasis (Psoriasis Vulgaris)
$ORKAOruka Therapeutics, Inc.
0 catalysts
Phase 2
PH-10
Xantryl
Atopic Dermatitis (Atopic Eczema)
$PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
0 catalysts
Phase 2
PVX-108
Peanut Allergy
Aravax Pty Ltd
0 catalysts
Phase 2
Peanut SLIT-tablet
Peanut Allergy
ALK-Abello AS
0 catalysts
Phase 2
QT-019B
Systemic Lupus Erythematosus
Hangzhou Qihan Biotechnology Co Ltd
0 catalysts